Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (2741)	1/31/2001 1:15:28 PM
From: nigel bates	Read Replies (2) \| Respond to of 52153

Where do you find these stocks <g> "O-list" ?? nig Jan. 30, 2001--Biora AB (NASDAQ: BIORY, SSE: BIOR) announces today that, the Federal Drug Administration, FDA, has given Biora approval to sell its newest product for treatment of periodontitis, Emdogain Gel, in the U.S. This is the largest market in the world- approximately 2.3 million procedures to regenerate tooth supporting structure are performed annually... Biora's ordinary shares are listed on the ``O-list'' of the Stockholm Stock Exchange in Sweden.